TPNUQ genotyping assay
Test in Focus
Mayo Clinic Laboratories’ TPNUQ genotyping assay is an innovative evaluation that examines two genes with known associations to thiopurine metabolism. In this “Test in Focus” episode of the "Answers From the Lab" podcast, Ann Moyer, M.D., Ph.D., explains how TPNUQ, when used in combination with enzyme activity testing, provides insight on a patient’s risk for thiopurine toxicity.
“It’s really important to do this testing before (patients) are actually prescribed that first dose of their medication,” Dr. Moyer says. “It has been included in the FDA label to test for both TPMT and NUDT15 prior to starting a thiopurine because we know that these drugs can be very toxic to those individuals that have reduced metabolism.”
TPNUQ’s ability to detect for variations in two genes enables insights for more patients, says Dr. Moyer. “If a patient happens to have an NUDT15 variant and not a TPMT variant, we used to just miss them. So, especially since we're in the United States and we've got a lot of population diversity, I think it's really important to include both TPMT and NUDT15 together, because that's the best way to predict which patients are at risk of toxicity.”
Listen to learn more about how TPNUQ can help clarify patients’ ability to metabolize thiopurines and optimize outcomes.
Note: Podcasts will not play back on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.
Multiple genotype tests can be performed on a single specimen after a single extraction. See Multiple Genotype Test List for a list of tests that can be ordered together.
Submit only 1 of the following specimens:
Specimen Type: Whole blood
Container/Tube: Lavender top (EDTA)
Specimen Volume: 3 mL
Specimen Stability Information: Ambient (preferred) 9 days/Refrigerated 30 days
Specimen Type: Saliva
Patient Preparation: Patient should not eat, drink, smoke, or chew gum 30 minutes prior to collection.
Supplies: Saliva Swab Collection Kit (T786)
Specimen Volume: 1 Swab
Collection Instructions: Collect and send specimen per kit instructions.
Specimen Stability Information: Ambient 30 days
Specimen Type: Extracted DNA
Container/Tube: 2-mL screw top tube
Specimen Volume: 100 mcL
Specimen Stability Information: Frozen (preferred)/Ambient/Refrigerated
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Joseph Maleszewksi, M.D., and Marie-Christine Aubry, M.D., explain how Mayo Clinic Laboratory can provide definitive diagnosis of primary ciliary dyskinesia (PCD). Mayo Clinic's expertise and technology have earned the laboratory's designation as the sole center of excellence for diagnosing this rare respiratory disorder.
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new direct biomarker test for alcohol consumption. PETH is a blood test with a window of detection of about two to four weeks — compared with five days for urine-based screening for alcohol use.